2.04
price down icon3.77%   -0.08
after-market Dopo l'orario di chiusura: 2.04
loading

Gain Therapeutics Inc Azioni (GANX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - -0.3052 0.1054
Operating Expenses
5.97%
4.7858
5.0895 4.3694 3.3311 4.459
Operating Income/Loss
5.97%
-4.7858
-5.0895 -4.3694 -3.3311 -4.459
Income/Loss From Continuing Operations Before Tax
16.46%
-4.7351
-5.6679 -4.4295 -3.2635 -4.4747
Income Tax Expense/Benefit
289.00%
0.5493
0.1412 0.1005 0.5047 0.011
Income/Loss From Continuing Operations After Tax
9.03%
-5.2844
-5.8091 -4.5301 -3.7682 -4.4857
Net Income/Loss
9.03%
-5.2844
-5.8091 -4.5301 -3.7682 -4.4857
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
15.35%
35.00
30.34 28.69 1.608 26.53
Diluted Average Shares
15.35%
35.00
30.34 28.69 1.608 26.53
Basic Earnings Per Share
21.05%
-0.15
-0.19 -0.16 -0.11 -0.17
Diluted Earnings Per Share
21.05%
-0.15
-0.19 -0.16 -0.11 -0.17
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$64.46
price up icon 1.80%
$36.24
price up icon 0.11%
$59.45
price up icon 1.45%
$128.32
price up icon 3.70%
$224.60
price down icon 1.77%
ONC ONC
$362.51
price up icon 4.33%
Capitalizzazione:     |  Volume (24 ore):